|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Center for Research Resources (NCRR) Louisiana State University |
|---|---|
| Information provided by: | National Center for Research Resources (NCRR) |
| ClinicalTrials.gov Identifier: | NCT00004375 |
Purpose
OBJECTIVES:
I. Evaluate the mechanisms of ultraviolet A-1 light therapy in patients with systemic lupus erythematosus and normal controls.
| Condition | Intervention | Phase |
|---|---|---|
|
Systemic Lupus Erythematosus |
Procedure: ultraviolet A-1 light treatment |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment |
| Estimated Enrollment: | 20 |
| Study Start Date: | September 1991 |
PROTOCOL OUTLINE:
Treatment with ultraviolet A-1 light is administered 5 days a week for 6 weeks, at the lowest dose or frequency required to maintain a response. The dose and frequency are progressively decreased over the next 9 weeks.
Eligibility| Ages Eligible for Study: | 15 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics--
Patients ages 15 to 70 with symptomatic systemic lupus erythematosus meeting American Rheumatism Association criteria and normal controls
--Prior/Concurrent Therapy--
No requirement for tetracycline or other photosensitizing drugs
Contacts and Locations| United States, Louisiana | |
| Alton Ochsner Medical Foundation Hospital | Recruiting |
| New Orleans, Louisiana, United States, 70121 | |
| Contact: Jawed Alam 504-842-3314 | |
| General Clinical Research Center and Charity Hospital (University of Louisiana) | Recruiting |
| New Orleans, Louisiana, United States, 70112-2822 | |
| Contact: Hugh McGrath, Jr. 504-568-4630 hmcgra@lsuhsc.edu | |
| Study Chair: | Hugh McGrath, Jr. | Louisiana State University |
More Information
| Study ID Numbers: | NCRR-M01RR05096-0002, LSUMC-1765, LSUMC-910067 |
| Study First Received: | October 18, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00004375 History of Changes |
| Health Authority: | United States: Federal Government |
|
arthritis & connective tissue diseases immunologic disorders and infectious disorders rare disease systemic lupus erythematosus |
|
Autoimmune Diseases Lupus Erythematosus, Systemic Lupus |
Arthritis Rare Diseases Connective Tissue Diseases |
|
Autoimmune Diseases Immune System Diseases Lupus Erythematosus, Systemic Connective Tissue Diseases |
